phase readout
saveNCT07282600: A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Overweight, Obesity
view source ↗
comments(0)
5-min edit window · permanent after that